Founded in 2021, Curelink operates in Enterprise Tech industry. Initially targeting the streamlining of doctor-patient communication through digital channels, the company has evolved to enhance health...
Funding stage:
Seed
Last funding:
15/03/2022
Total funding:
$3.55 Mn+
Revenue:
Investors
Employee count:
99
Last 90d
99
Last 90d
Web traffic:
2.77K
2.77K
Last 30d
Last 30d
Glassdoor Rating:
Curelink: Cap Table Highlights
A snapshot of cap table and shareholder metrics
Total Shareholders18
Latest Filing Date30 March 2025- Funding Events2
Event-Based View
Event-Based detailed View by Filings
FAQs on Cap Table of Curelink
As of 31 March 2025, Curelink's equity is held by 18 shareholders, with the top three being Aman Singla, Divyansh Jain, and Elevation Capital VII Limited.
Aman Singla holds the largest stake in Curelink at 41.1% as of 31 March 2025.
Disclaimer
Inc42 Datalabs consolidates intelligence from public records, statutory filings, proprietary research, and vetted third‑party datasets. All information is provided as is—please run your own checks before acting on it. Inc42 Datalabs bears no responsibility for decisions or outcomes based on this data.
Quick Links